quinoxalines has been researched along with akt-i-1 compound in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, SF; Defeo-Jones, D; Fu, S; Hancock, PJ; Haskell, KM; Huber, HE; Jones, RE; Kahana, JA; Kral, AM; Leander, K; Lee, LL; Malinowski, J; McAvoy, EM; Nahas, DD; Robinson, RG | 1 |
1 other study(ies) available for quinoxalines and akt-i-1 compound
| Article | Year |
|---|---|
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Adenosine Triphosphate; Apoptosis Regulatory Proteins; Benzylamines; Binding, Competitive; Blood Proteins; Carcinoma; Caspases; Cell Line, Tumor; Cloning, Molecular; Enzyme Activation; Enzyme Inhibitors; Female; Heterocyclic Compounds, 2-Ring; Humans; Isoenzymes; Male; Membrane Glycoproteins; Molecular Structure; Peptides; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinoxalines; Sequence Homology, Amino Acid; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 2005 |